Legal Representation
Attorney
Carolyn M. Gouges d'Agincourt
USPTO Deadlines
Next Renewal Deadline
225 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-02-18)
Due Date
February 18, 2026
Grace Period Ends
August 18, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
37 eventsDate | Code | Type | Description |
---|---|---|---|
Apr 16, 2025 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Mar 25, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Mar 25, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Mar 25, 2025 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Mar 25, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Mar 25, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Mar 25, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Dec 6, 2024 | WOAG | I | WITHDRAWAL OF ATTORNEY GRANTED |
Dec 6, 2024 | WOAR | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
Dec 6, 2024 | EWOR | I | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
Dec 6, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Dec 6, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Feb 18, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Jan 15, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Jan 15, 2020 | DP1B | I | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
Nov 26, 2019 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED |
Nov 26, 2019 | D1BR | I | TEAS DELETE 1(B) BASIS RECEIVED |
Oct 16, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Oct 16, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Oct 1, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Aug 6, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Aug 6, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jul 17, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jul 10, 2019 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Jun 28, 2019 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE |
Jun 21, 2019 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
Jun 19, 2019 | ALIE | A | ASSIGNED TO LIE |
Jun 6, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jun 5, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jun 5, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jun 5, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Apr 9, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Apr 9, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED |
Apr 9, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
Apr 9, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
Feb 20, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Jan 31, 2019 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceuticals for treatment of mucosal diseases; pharmaceutical preparations and substances for treatment of mucosal diseases; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for treating mucous membrane disorders; pharmaceutical preparations, namely, muco adhesive patches for efficient and uniform drug release; medicine for treatment of mucosal diseases; medical preparations and articles for treatment of mucosal diseases; medical preparations and articles, namely, mucous membrane- and skin- adhesive patches for coverage of lesions and/or efficient and uniform drug delivery; patches for treatment of mucosal diseases; adhesive patches for medical purposes, namely for treatment of mucosal diseases; skin patches for the transdermal delivery of pharmaceuticals for use in the treatment of mucosal diseases; mucous membrane patches for the transdermal delivery of pharmaceuticals for use in the treatment of mucosal diseases; transdermal patches for use in the treatment of mucosal diseases; transdermal patches for medical treatment for use in the treatment of mucosal diseases; transmucosal patches for medical treatment of mucosal diseases; dressings, medical; adhesive dressings; dressings for wounds; bandages, medical; adhesive bandages; bandages for skin wounds; bandages for mucous membrane wounds; mucosal surface delivery of pharmaceuticals for use in the treatment of mucosal diseases
Class 042
Scientific, medical and pharmaceutical research and development services; research and development of pharmaceutical preparations; research and development of pharmaceutical preparations for treating skin disorders; research and development of pharmaceutical preparations for treating mucous membrane disorders; research and development of pharmaceutical preparations, namely, muco adhesive patches for efficient and uniform drug release; research and development of medicines; research and development of medical preparations and articles; research and development of medical preparations and articles, namely, mucous membrane- and skin- adhesive patches for coverage of lesions and/or efficient and uniform drug delivery; medical research and analysis services; biological research; clinical research in the field of treatment of mucosal diseases; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals
Class 044
Medical services; medical treatment services; medical screening; medical monitoring, testing, inspection and analysis services; medical services relating to the diagnosis and treatment of skin disorders; medical services relating to the diagnosis and treatment of mucous membrane disorders; pharmaceutical compounding services; pharmaceutical advisory services; dermatological services for treating skin conditions; dermatological services for treating mucous membrane conditions; laboratory analysis services relating to the diagnosis and treatment of skin disorders; medical laboratory analysis services provided by medical laboratories relating to the diagnosis and treatment of mucous membrane disorders
Classification
International Classes
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"